Cargando…

The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model

BACKGROUND AND OBJECTIVES: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, In-Ho, Jeong, Myung Ho, Kim, Ju Han, Park, Yong Hwan, Lim, Kyung Seob, Park, Dae Sung, Shim, Jae Won, Kim, Jung Ha, Ahn, Youngkeun, Hong, Young Joon, Sim, Doo Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287174/
https://www.ncbi.nlm.nih.gov/pubmed/28154600
http://dx.doi.org/10.4070/kcj.2016.0203
_version_ 1782504120301649920
author Bae, In-Ho
Jeong, Myung Ho
Kim, Ju Han
Park, Yong Hwan
Lim, Kyung Seob
Park, Dae Sung
Shim, Jae Won
Kim, Jung Ha
Ahn, Youngkeun
Hong, Young Joon
Sim, Doo Sun
author_facet Bae, In-Ho
Jeong, Myung Ho
Kim, Ju Han
Park, Yong Hwan
Lim, Kyung Seob
Park, Dae Sung
Shim, Jae Won
Kim, Jung Ha
Ahn, Youngkeun
Hong, Young Joon
Sim, Doo Sun
author_sort Bae, In-Ho
collection PubMed
description BACKGROUND AND OBJECTIVES: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel (PTX)-eluting stent via simple ionic interactions and to evaluate its effects in vitro and in vivo. MATERIALS AND METHODS: HA and catechol were conjugated by means of an activation agent, and then the stent was immersed in this solution (resulting in a HA-coated stent). After that, PTX was immobilized on the HA-coated stent (resulting in a hyaluronic acid-coated paclitaxel-eluting stent [H-PTX stent]). Study groups were divided into 4 groups: bare metal stent (BMS), HA, H-PTX, and poly (L-lactide)-coated paclitaxel-eluting stent (P-PTX). Stents were randomly implanted in a porcine coronary artery. After 4 weeks, vessels surrounding the stents were isolated and subjected to various analyses. RESULTS: Smoothness of the surface was maintained after expansion of the stent. In contrast to a previous study on a PTX-eluting stent, in this study, the PTX was effectively released up to 14 days (a half amount of PTX in 4 days). The proliferation of smooth muscle cells was successfully inhibited (by 80.5±12.11% at 7 days of culture as compared to the control) by PTX released from the stent. Animal experiments showed that the H-PTX stent does not induce an obvious inflammatory response. Nevertheless, restenosis was clearly decreased in the H-PTX stent group (9.8±3.25%) compared to the bare-metal stent group (29.7±8.11%). CONCLUSION: A stent was stably coated with PTX via simple ionic interactions with HA. Restenosis was decreased in the H-PTX group. These results suggest that HA, a natural polymer, is suitable for fabrication of drug-eluting stents (without inflammation) as an alternative to a synthetic polymer.
format Online
Article
Text
id pubmed-5287174
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-52871742017-02-02 The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model Bae, In-Ho Jeong, Myung Ho Kim, Ju Han Park, Yong Hwan Lim, Kyung Seob Park, Dae Sung Shim, Jae Won Kim, Jung Ha Ahn, Youngkeun Hong, Young Joon Sim, Doo Sun Korean Circ J Original Article BACKGROUND AND OBJECTIVES: Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel (PTX)-eluting stent via simple ionic interactions and to evaluate its effects in vitro and in vivo. MATERIALS AND METHODS: HA and catechol were conjugated by means of an activation agent, and then the stent was immersed in this solution (resulting in a HA-coated stent). After that, PTX was immobilized on the HA-coated stent (resulting in a hyaluronic acid-coated paclitaxel-eluting stent [H-PTX stent]). Study groups were divided into 4 groups: bare metal stent (BMS), HA, H-PTX, and poly (L-lactide)-coated paclitaxel-eluting stent (P-PTX). Stents were randomly implanted in a porcine coronary artery. After 4 weeks, vessels surrounding the stents were isolated and subjected to various analyses. RESULTS: Smoothness of the surface was maintained after expansion of the stent. In contrast to a previous study on a PTX-eluting stent, in this study, the PTX was effectively released up to 14 days (a half amount of PTX in 4 days). The proliferation of smooth muscle cells was successfully inhibited (by 80.5±12.11% at 7 days of culture as compared to the control) by PTX released from the stent. Animal experiments showed that the H-PTX stent does not induce an obvious inflammatory response. Nevertheless, restenosis was clearly decreased in the H-PTX stent group (9.8±3.25%) compared to the bare-metal stent group (29.7±8.11%). CONCLUSION: A stent was stably coated with PTX via simple ionic interactions with HA. Restenosis was decreased in the H-PTX group. These results suggest that HA, a natural polymer, is suitable for fabrication of drug-eluting stents (without inflammation) as an alternative to a synthetic polymer. The Korean Society of Cardiology 2017-01 2016-12-23 /pmc/articles/PMC5287174/ /pubmed/28154600 http://dx.doi.org/10.4070/kcj.2016.0203 Text en Copyright © 2017 The Korean Society of Cardiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bae, In-Ho
Jeong, Myung Ho
Kim, Ju Han
Park, Yong Hwan
Lim, Kyung Seob
Park, Dae Sung
Shim, Jae Won
Kim, Jung Ha
Ahn, Youngkeun
Hong, Young Joon
Sim, Doo Sun
The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title_full The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title_fullStr The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title_full_unstemmed The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title_short The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
title_sort control of drug release and vascular endothelialization after hyaluronic acid-coated paclitaxel multi-layer coating stent implantation in porcine coronary restenosis model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287174/
https://www.ncbi.nlm.nih.gov/pubmed/28154600
http://dx.doi.org/10.4070/kcj.2016.0203
work_keys_str_mv AT baeinho thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT jeongmyungho thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT kimjuhan thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT parkyonghwan thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT limkyungseob thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT parkdaesung thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT shimjaewon thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT kimjungha thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT ahnyoungkeun thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT hongyoungjoon thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT simdoosun thecontrolofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT baeinho controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT jeongmyungho controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT kimjuhan controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT parkyonghwan controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT limkyungseob controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT parkdaesung controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT shimjaewon controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT kimjungha controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT ahnyoungkeun controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT hongyoungjoon controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel
AT simdoosun controlofdrugreleaseandvascularendothelializationafterhyaluronicacidcoatedpaclitaxelmultilayercoatingstentimplantationinporcinecoronaryrestenosismodel